Roth MKM Maintains Buy on Trulieve Cannabis, Raises Price Target to $19
Portfolio Pulse from Benzinga Newsdesk
Roth MKM analyst Scott Fortune has maintained a Buy rating on Trulieve Cannabis (OTC:TCNNF) and increased the price target from $16 to $19. This adjustment reflects a positive outlook on the company's future performance.
May 10, 2024 | 2:18 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Roth MKM's updated Buy rating and increased price target for Trulieve Cannabis indicates a strong confidence in the company's future performance and growth potential.
The analyst's decision to maintain a Buy rating and raise the price target suggests a strong belief in Trulieve Cannabis's operational and financial health. This could lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100